Neuroendocrine markers of CNS drug effects.
1980; Wiley; Volume: 10; Issue: 1 Linguagem: Holandês
10.1111/j.1365-2125.1980.tb00497.x
ISSN1365-2125
AutoresEC Johnstone, I. Nicol Ferrier,
Tópico(s)Pharmacological Effects and Toxicity Studies
ResumoBritish Journal of Clinical PharmacologyVolume 10, Issue 1 p. 5-21 Free Access Neuroendocrine markers of CNS drug effects. EC Johnstone, EC JohnstoneSearch for more papers by this authorIN Ferrier, IN FerrierSearch for more papers by this author EC Johnstone, EC JohnstoneSearch for more papers by this authorIN Ferrier, IN FerrierSearch for more papers by this author First published: July 1980 https://doi.org/10.1111/j.1365-2125.1980.tb00497.xCitations: 20AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat References ANNUNZIATO, L. (1979). Regulation of the tuberoinfun-dibular and nigrostriatal systems. Neuroendocrinology, 29, 66– 76. ARENDASH, G.W. & GALLO, R.V. (1978). Apomorphine induced inhibition of episodic LH release on ovariectomized rats with complete hypothalamic de-afferentation. Proc. Soc. exp. Biol. Med., 159, 121– 125. BAASTRUP, P.C. & SCHOU, (1967). Lithium as a prophylactic agent. Arch. Gen. Psychiat., 16, 163– 172. BARLOW, S.M., KNIGHT, A.F. & SULLIVAN, F.M. (1979). Plasma corticosterone responses to stress following chronic oral administration of diazepam in the rat. J. Pharm. Pharmac., 31, 23– 26. BEG, A.A., VARMA, V.K. & DASH, R.J. (1979). Effect of chlorpromazine on human growth hormone. Am. J. Psychiat., 136, 914– 917. BEN-JONATHAN, N., OLIVER, C., WEINER, H.J., MICAL, R.S. & PORTER, J.C. (1977). Dopamine in hypophysial portal plasma of the rat during the oestrous cycle and throughout pregnancy. Endocrinology, 100, 452– 458. BENNETT, G.W., EDWARDSON, J.A., HOLLAND, O., JEFFCOATE, S.L. & WHITE, N. (1975). Release of immunoreactive luteinizing hormone-releasing hormone and thyrotrophin-releasing hormone from hypothalamic synaptosomes. Nature, 257, 323– 325. BENOWITZ, N.L., JONES, R.T. & LERNER, C.B. (1976). Depression of growth hormone and cortisol response to insulin-induced hypoglycaemia after prolonged oral delta-9-tetra hydrocannabinol administration in man. J. clin. Endocrinol. Metab., 42, 938– 941. BERNHEIMER, H., BIRKMAYER, W., HORNYKIEWICZ, O., JELLINGER, K. & SEITELBERGER, F. (1973). Brain dopamine and the syndromes of Parkinson and Huntington. J. Neurol. Sci., 20, 415– 455. BERSON, S.A. & YALOW, R.S. (1968). General Principle of radioimmunoassay. Clin. Chem. Acta, 22, 51– 69. BESSER, G.M., PARKE, L., EDWARDS, C.R.W., FORSYTH, I.A. & McNEILLY, A.S. (1972). Galactorrhoea; successful treatment with reduction of plasma prolactin levels by bromergocryptine (1972). Br. med. J., 3, 669– 672. BESSES, G.S., BURROW, G.N. SPAULDING, S.W. & DONABEDIAN, R.K. (1975). Dopamine infusion acutely inhibits the TSH and prolactin response to TRH. J. clin. Endocrinol. Metab., 41, 985– 988. BEUMONT, P.J.V. (1979). The endocrinology of psychiatry. In Recent Advances in Clinical Psychiatry, ed. K. Granville-Grossman London: Churchill-Livingstone. BEUMONT, P.J.V., CORKER, C.S., FRIESEN, H.G., GELDER, M.G., HARRIS, G.W., KOLAKOWSKA, T., MACKINNON, P.C.B., MANDELBROTE, B.M., MARSHALL, J., MURRAY, M.A.F., & WILES, D.H. (1974). The effects of phenothiazines on endocrine function I. Patients with inappropriate lactation and amenorrhoea II. Effects in men and post-menopausal women. Br. J. Psychiat., 124, 413– 430. BIRD, E.D. & IVERSEN L.L. (1974). Huntington's chorea. Post-mortem measurement of glutamine acid decarboxy-lase, choline acetytransferase and dopamine in basal ganglia. Brain, 97, 457– 472. BIRGE, C.A., JACOBS, L.S., HAMMER, C.J. & DAUGHADAY, W.H. (1970). Catecholamine inhibition of prolactin secretion by isolated rat adenohypophyses. Endocrinology, 86, 120– 130. BIVENS, C.H., LEBOVITZ, H.E. & FELDMAN, L.M. (1973). Inhibition of hypoglycaemia-induced growth hormone secretion by the serotonin antagonists cyproheptadine and methysergide. New Engl. J. Med., 289, 236– 239. BLACKWELL, B., (1973). Psychotropic drugs in use today. J. Am. Med. Ass., 225, 1637– 1641. BRAMBILLA, F., GUERRINI, A., GUASTALLA, A., ROVERE, C. & RIGGI, F. (1975). Neuroendocrine effects of haloperidol therapy in chronic schizophrenia. Psychopharmacology, 44, 17– 22. BRAMBILLA, F., RESELE, L. & DE NOBILE, MAIO P. (1979). Gonadotropin response to synthetic gonadotropin hormone releasing hormone (GnRH) in heroin addicts. Am. J. Psychiat., 135, 314– 317. BRAMBILLA, F., SACCHETTI, E. & BRUNETTA, M. (1977). Pituitary-gonadal function in heroin addicts. Neuro-psychobiology, 3, 65– 74. BROWN, G.M., SEEMAN, P. & LEE, T. (1976). Dopamine/neuroleptic receptors in basal hypothalamus and pituitary. Endocrinology, 99, 1407– 1410. BROWN, W.A. LAUGHREN, T.P. & ROBZYK, P.H. (1979). Serum prolactin in humans parallels neuroleptic induced changes in dopamine receptor sensitivity. Society for Neurosciences, 9th Annual Meeting, Atlanta, Georgia. Extract No. 1482. BRUNI, J.F., VAN VOGT, D., MARSHALL, S. & MEITES, J. (1977). Effects of naloxone, morphine and methionine encephalin on serum prolactin, luteinizing hormone, thyroid stimulating hormone and growth hormone. Life Sci., 21, 461– 466. BURROW, G.N., MAY, P.B., SPAULDING, S.W. & DONABEDIAN, N.K. (1977). TRH and dopamine interactions affecting pituitary hormone secretion. J. clin. Endocrinol. Metab., 45, 65– 72. CADE, J.F.J. (1949). Lithium salts in the treatment of psychotic excitement. Med. J. Aust., 2, 349– 352. CAMANNI, F., MASSARA, F., BELFORTE, L. & MOLINATTI, G.M. (1975). Changes in plasma growth hormone levels in normal and acromegalic subjects, following 2-br-α ergocryptine. J. clin. Endocrinol. Metab., 40, 363– 366. CAMANNI, F., MASSARA, F., BELFORTE, L., ROSATELLO, N. & MOLINATTI, G.M. (1977). Effects of dopamine on growth hormone and prolactin levels in normals and acromegalic subjects. J. clin. Endocrinol. Metab., 44, 465– 473. CARACENI, T.A., PARATE, E.A., COCCHI, D., PANERAI, A.E. & MULLER, E.E. (1977). Altered growth hormone and prolactin responses to dopaminergic stimulation in Huntington's chorea. J. clin. Endocrinol. Metab. 44, 870– 875. CHALMERS, R.J., BENNIE, E.H., JOHNSON, R.H. & KINNELL, H.G. (1977). The growth hormone response to insulin induced hypoglycaemia in alcoholics. Psychol. Med., 7, 607– 611. CHALMERS, R.J., JOHNSON, R.H., KEOGH, H.J. & NANDA, R.N. (1978). Growth hormone and prolactin response to bromocriptine in patients with Huntington's chorea. J. Neurol. Neurosurg. Psychiat., 41, 135– 139. CHECKLEY, S.A. (1979). Corticosteroid and growth hormones response to methylamphetamine in depressive illness. Psychol. Med., 9, 107– 116. CHECKLEY, S.A. (1980). Neuroendocrine tests of monoamine function in man: a review of basic theory and the application to the study of depressive illness. Psychol. Med., 10, 35– 53. CHIHARA, K., KATO, Y., MAEDA, K., MATSUKARA, S., IMURA, (1976). Suppression by cyproheptadine of human growth hormone and cortisol secretion during sleep. J. clin. Invest., 57, 1393– 1402. CHRISTY, N.P., LONGSON, D.S., HOROWITZ, W.A. & KNIGHT, M.M. (1957). Inhibitory effect of chlorpromazine upon the adrenal cortical response to insulin hypoglycaemia in man. J. clin. Invest., 36, 543– 549. CICERO, T.J., BELL, R.D., WEST, W.G., ALLISON, L.H., POLAKOSKI, K. & ROBINS, E. (1975). Function of the male sex organs in heroin and methadone users. New Engl. J. Med., 292, 882– 887. COCCHI, D., GIL-AD, I., PARENTI, M., STEFANINI, E., LOCATELLI, V. & MULLER, E.E. (1980). Prolactin-releasing effect of a novel anti-dopaminergic drug, domperidone, in the rat. Neuroendocrinology, 30, 65– 69. COPPEN, A. & GHOSE, K. (1978). Peripheral α-adrenoceptor and central dopamine receptor activity in depressed patients. Psychopharmacology, 59, 171– 177. COPPEN, A., PEET, M., MONTGOMERY, S. & BAILEY, J. (1974). Thyrotrophin-releasing hormone in the treatment of depression. Lancet, ii, 433– 435. COTES, P.M., CROW, T.J., JOHNSTONE, E.C., BARTLETT, W. & BOURNE, R.C. (1978). Neuroendocrine changes in acute schizophrenia as a function of clinical state and neuroleptic medication. Psychol. Med., 8, 657– 665. CREESE, I., BURT, D.R. & SNYDER, S.H. (1976). Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. Science, 192, 481– 483. CUSHMAN, P. (1973). Plasma testosterone in narcotic addiction. Am. J. Med., 55, 452– 458. DELITALA, G., WASS, J.A.H., STUBBS, W.A., JONES, A., WILLIAMS, S. & BESSER, G.M. (1979). The effect of lisuride hydrogen maleate, an ergot derivative on anterior pituitary secretion in man. Clin. Endocrinol., 11, 1– 9. DE RIVERA, J.L., LAL, S., ETTIGI, P., MANTELLA, S., MILLER, H.F. & FREISEN, H.G. (1976). Effect of acute and chronic neuroleptic therapy on serum prolactin levels in men and women of different age groups. Clin. Endocrinol., 5, 273– 282. DE WIED, (1967). Chlorpromazine and endocrine function. Pharmac. Rev., 19, 251– 298. DIBBETT, S.A., BONDREAU, M.J., BRUNI, J.F. & MEITES, J. (1974). Possible role of dopamine in modifying prolactin (PRL) response to TRH. Proc. 56th Annual Meeting. Am. Endocrinol. Soc. Atlanta, p. 186. DIEFENBACH, W.M.P., CARMEL, P.W., FRANTZ, A.G. & FERIN, M. (1976). Suppression of prolactin secretion by L-DOPA in the stalk sectional rhesus monkey. J. clin. Endocrinol. Metab., 43, 638– 642. DROUVA, S.V. & GALLO, R.V. (1977). Further evidence for inhibition of episodic luteinizing hormone release in ovariectomized rats by stimulation of dopamine receptors. Endocrinology, 100, 792– 798. DUNNE, M.J., WALKER, J., COWDEN, E.A., & RATCLIFFE, J.G. (1979). Nomifensine test for investigation of hyperprolactinaemia. Lancet, ii, 1243. ETTIGI, P.G. & BROWN, G.M. (1977). Psychoneuroendocrinology of affective disorder: an overview. Am. J. Psychiat. 134, 493– 501. ETTIGI, P.G., NAIR, N.P.W., LAL, S., CERVANTES, P. & GUYDA, H. (1976). Effect of apomorphine on growth hormone and prolactin secretion in schizophrenic patients with or without oral dyskinisia, withdrawn from chronic neuroleptic therapy. J. Neurol. Neurosurg. Psychiat., 39, 870– 876. FORREST, J.N., COHEN, A.D., TORRETTI, J., HIMMELHOCH, J. & EPSTEIN, F.H. (1974). On the mechanism of lithium-induced diabetes insipidus in man and the rat. J. clin. Invest., 53, 1115– 1123. FRIEND, W.C., BROWN, G.M., JAWAHIR, G., LEE, T. & SEEMAN, P. (1978). Effect of haloperidol and apomorphine treatment on dopamine receptors in pituitary and striatum. Am. J. Psychiat. 135, 839– 841. FRIESEN, H.G., GUYDA, H., HWANG, P., TYSON, J.E. & BARBEAU, A. (1972). Functional evaluation of prolactin secretion: a guide to therapy. J. clin. Invest., 51, 706– 709. FUXE, K. (1979). Dopamine receptor agonists in brain research and therapeutic agents. Trends in Neurosciences, 2, 1– 5. FUXE, K. & HOKFELT, T. (1969). Catecholamines in the hypothalamus and the pituitary gland. In eds Ganong, W.F. & Martini, L. Frontiers in Neuroendocrinology, New York: Oxford University Press. GALLAGER, D.W., PERT, A. & BUNNEY, W.E. (1978). Haloperidol-induced presynaptic dopamine supersensitivity is blocked by chronic lithium. Nature, 273, 309– 312. GENERAL PRACTITIONER CLINICAL TRIALS (1970). A weight-promoting drug. Practitioner, 205, 101– 105. GIL-AD, I., TOPPER, E. & LARON, Z. (1979). Oral clonidine as a growth hormone stimulation test. Lancet, ii, 278– 279. GOLD, P.W., GOODWIN, F.K., WEHR, T. & REBAR, R. & SACK, R. (1976). Growth hormone and prolactin response to L-DOPA in affective illness Lancet, ii, 1308– 1309. GOLD, M.S. POTTASH, A.L.C., DAVIES, R.K., RYAN, N., SWEENEY, D.R. & MARTIN, D.M. (1979). Distinguishing unipolar and bipolar depression by thyrotropin release test. Lancet, ii, 411– 412. GOLD, M.S., REDMOND, D.E. & DONABEDIAN, R.K. (1978). Prolactin secretion: A measurable central effect of opiate receptor antagonists. Lancet, i, 323– 324. GRAHAME-SMITH, D. (1976). cit. by Crow, T.J. Deakin, J.F.W. Johnstone, E.C. & Longden, A. Dopamine and schizophrenia. Lancet, ii, 563– 566. GRUEN, P.H., SACHAR, E.J., ALTMAN, N., LEIFER, M., FRANTZ, A.G. & HALPERN, F.S. (1978a). Prolactin responses to neuroleptics in normal and schizophrenic subjects. Arch. Gen. Psychiat. 35, 108– 116. GRUEN, P.H., SACHAR, E.J., ALTMAN, N., LANGER, G., TABRIZI, M.A. & HALPERN, F.S. (1978b). Relation of plasma prolactin to clinical response in schizophrenic patients. Arch. Gen. Psychiat., 35, 1222– 12227. GRUEN, P.H., SACHAR, E.J., ALTMAN, N. & SASSIN, H. (1975). Growth hormone response to hypoglycaemia in post-menopausal depressed women. Arch. Gen. Psychiat., 32, 31– 33. GUDELSKY, G.A. & MOORE, K.F. (1976). Differential drug effects on dopamine concentrations and rates of turnover in the median eminence, olfactory tubercle and corpus striatum. J. Neurol. Transmission, 38, 96– 105. HALMI, K.A. & GOLDBERG, S.C., (1978). Cyproheptadine in anorexia nervosa. Psychopharmac. Bull., 14, 31– 33. HANSSEN, T., HEYDEN, T., SUNDBERG, I., WETTERBERG, L. & ENROTH, P. (1978). Decrease in propranolol in schizophrenia. Lancet, i, 101– 102. HAYEK, A. & CRAWFORD, J.D. (1972). L-Dopa and pituitary hormone secretion. J. clin. Endocrinol. Metab., 34, 764– 766. HEALEY, D.L. & BURGER, H.G. (1977). Increased prolactin and thyrotrophin secretion following oral metoclopramide: dose-response relationships. Clin. Endocrinol., 7, 195– 201. HIMSWORTH, R.L., CARMEL, P.W. & FRANTZ, A.G. (1972). The location of the chemoreceptor controlling growth hormone secretion during hypoglycaemia in primates. Endocrinology, 91, 217– 226. HOLLISTER, L.E., DAVIS, K.L. & BERGER, P.A. (1976). Pituitary response to thyrotropin releasing hormone in depression. Arch. Gen. Psychiat., 33, 1393– 1396. HUWS, D. & GROOM, G.V. (1977). Luteinizing hormone releasing hormone and thyrotrophin releasing hormone stimulation studies in patients given clomipramine or ‘depot’ neuroleptics. Postgrad. med. J., 53, (Suppl. 4), 175– 181. HYYPPA, M.T. (1978). Plasma pituitary hormones in patients with Parkinson's disease treated with bromocriptine. J. Neurol. Transmission, 42, 151– 7. IDANPAAN-HAKKILA, J., ALHAVA, E. & OLKINVORA, M. (1977). Agranulocytosis during treatment with clozapine. Eur. J. clin. Pharmac., 11, 193– 198. IMURA, H., NAKAI, Y. & YOSHIMI, T. (1973). Effect of 5-hydroxytryptophan (5-HTP) on growth hormone and ACTH release in man. J. clin. Endocrinol. Metab., 36, 204– 206. IVERSEN, L.L. & MacKAY, A.V.P. (1979). Pharmacodynamics of antidepressants and antimanic drugs. In Psychopharmacology of Affective Disorders, eds. E.S. Paykel & A. Coppen Oxford: Oxford University Press. JANOWSKY, D., JUDD, L., HUEY, L., PORTMAN, L. & PARKER, D. (1979). Naloxone effects on serum growth hormone and prolactin in man. Psychopharmacology, 65, 95– 97. JOHNSTONE, E.C. (1980). Affective Disorders In Disorders of Neurotransmission, ed. T.J. Crow New York: Academic Press (in press). JOHNSTONE, E.C., CROW, T.J. & MASHITER, K. (1977). Anterior putuitary hormone secretion in chronic schizophrenia—an approach to neurohumeral mechanisms. Psychol. Med. 7, 223– 228. JONES, R.B., LUSCOMBE D.K. & GROOM G.V. (1977). Plasma prolactin concentrations in normal subjects and depressive patients following oral domperidone. Post grad. med. J., 53, (Suppl. 4), 166– 171. KAMBERI, I.A., MICAL, R.S. & PORTER, J.C. (1971). Effect of anterior pituitary perfusion and intraventricular injection of catecholamines on prolactin release. Endocrinology, 88, 1012– 1020. KIM, S., SHERMAN, L., KOLODNY, H.D., BENJAMIN, F. & SINGH, A. (1971). Attenuation by haloperidol of human serum growth hormone (HGH) by response to insulin. Clin. Res., 19, 718. KIRKEGAARD, C., NØRLEM, N., LAUNDSEN, U.B., BJØRUN, N. & CHRISTIANSEN, C. (1975). Protirelin stimulation test and thyroid function during treatment of depression. Arch. Gen. Psychiat., 32, 1115– 1118. KLEINBERG, D.L., WHARTON, R.N. & FRANTZ, A.G. (1971). Rapid release of prolactin in normal adults following chlorpromazine stimulation. 53rd Programme of Endocrine Society Meetings, San Francisco, 126. KOLAKOWSKA, T., WILES, D.H., McNEILLY, A.S. & GELDER, M.G. (1975). Correlation between plasma levels of prolactin and chlorpromazine in psychiatric patients. Psychol. Med., 5, 214– 216. KOLODNY, R.C., MASTERS, W.H., KOLODNER, R.M. & TORO, G. (1974). Depression of plasma testosterone levels after chronic intensive marihuana use. New Engl. J. Med., 290, 872– 874. KOULU, M., LAMMENTAUSTA, R. KANGAS, L. & DAHLSTROM, S. (1979). The effect of methysergide, pimozide and sodium valproate on the diazepam-stimulated growth hormone secretion in man. J. clin. Endocrinol. Metab., 48, 119– 122. LACHELIN, G.C.L., LEBLANC, H. & YEN, S.S.C. (1977). The inhibitory effects of dopamine agonists on LH release in women. J. clin. Endocrinol. Metab., 44, 728– 732. LAL, (1978). Effect of lithium on hypothalamic-pituitary dopaminergic function. Acta Psychiat. Scand., 57, 91– 6. LAL, H., BROWN, W., DRAWBURGH, R., HYNES, M., & BROWN G. (1977). Enhanced prolactin inhibition following chronic treatment with haloperidol and morphine. Life Sci., 20, 101– 106. LAL, S., DE LA VEGA, C.E., SOURKES, T.L. & FRIESEN, H.G. (1973). Effect of apomorphine on growth hormone, prolactin, luteinizing hormone, follicle stimulating hormone in human serum. J. clin. Endocrinol. Metab., 37, 719– 724. LAL, S., HARVEY, G. & BIKADOROFF, S. (1977). Effect of methysergide and pimozide on apomorphine induced growth hormone secretion in man. J. clin. Endocrinol. Metab., 44, 766– 770. LAL, S., MARTIN, J.B., DE LA VEGA, C., & FRIESEN, H. (1975). Comparison of the effect of apomorphine and levodopa on the serum hormone levels in normal men. Clin. Endocrinol., 4, 277– 285. LAL, S., TOLLIS, G., MARTIN, J.B., BROWN, G.M. & GUYDA, M. (1975). Effect of clonidine on growth hormone, prolactin, luteinizing, hormone folicle stimulating hormone and thyroid stimulating hormone in the serum of normal men. J. clin. Endocrinol. Metab., 41, 823– 832. LANGER, G., HEINZE, G., REIM, B. & MATUSSEK, N. (1976). Reduced growth hormone responses to amphetamine in ‘endogenous’ depressive patients. Arch. Gen. Psychiat., 33, 1471– 1475. LANGER, G. & MATUSSEK, N. (1977). D and L-amphetamine are equivalent in releasing human growth hormone. Psychoneuroendocrinology, 2, 379– 382. LANGER, G., SACHAR, E.J., NATHAN, R.S., TABRIEZI, M.A., PEREZ, J.M. & HALPERN, F.S. (1979). Dopaminergic factors in human prolactin regulators a pituitary model for the study of a neuroendocrine system in man. Psychopharmacology, 65, 161– 164. LANGER, G., SACHAR, E.J., GRUEN, P.H. & HALPERN, F.S. (1977). Human prolactin responses to neuroleptic drugs correlate with antischizophrenic potency. Nature, 266, 639– 640. LANGER, G., SCHONBECK, G., KORNIG, G., KESCH, O., SCHUSSLER, M. & WALDHAUSL, W. (1980). Antidepressant drugs and the hypothalamic pituitary thyroid axis. Lancet, i, 100. LAPIN, I.P. & OXENKRUG, G.F. (1969). Intensification of the central serotoninergic processes as a possible determinant of the thymoleptic effect. Lancet, i, 132– 136. LAVENSTEIN, A.F., DACANAY, E.P., HORVATH, J., LASAGNA, L.C. & VAN METRE, T.E. (1961). The effect of cyproheptadine on appetite and body weight. Am. J. Dis. Child., 102, 537. LAWSON, D.M. & GALA, R.R. (1975). The influence of adrenergic, dopaminergic, cholinergic and serotonergic drugs on plasma prolactin levels in ovarictomized, oestrogen treated rats. Endocrinology, 96, 313– 318. LEBLANC, H., LACHELIN, G.C.L., ABU-FADIL, S. & YEN, S.S.C. (1976). Effect of dopamine infusion on pituitary hormone secretion in humans. J. clin. Endocrinol. Metab., 43, 668– 674. LEEBAW, W.F., LEE, L.A. & WOOLF, P.O. (1978). Dopamine effect level and augmented pituitary hormone secretion. J. clin. Endocrinol. Metab., 47, 480– 487. LEPPALUOTO, J., MANNISTO, P. RANTA, T. & LINNOILA, M. (1976). Inhibition of mid-cycle gonadotrophin release in healthy women by pimozide and fusaric acid. Acta Endocrinol., 81, 455– 460. LIEN, E., FERUCHEL, R.L., GARSBY, D., SARANTAKO, D. & GRANT, N. (1976). Enkephalin—stimulated prolactin release. Life Sci., 19, 37– 40. LINDSTEDT, G., NILSSEN, L., WALINDER, J., SKOTT, A. & OHMAN, R. (1977). On the prevalence, diagnosis and management of lithium induced hypothyroidism in psychiatric patients. Br. J. Psychiat., 130, 452– 458. LIUZZI, A., PANERAI, A.E., CHIODINE, P.G., SECCHI, C., COCCHI, O., BOTALLA, L., SILVESTRINI, F. & MULLER, E.E. (1976). In Growth hormone and related peptides. eds A. Pecile & E.E. Muller, pp. 236– 251. Amsterdam: Excerpta Medica. LOOSEN, P.T., PRANGE, A.J. & WILSON, I.C. (1979). TRH (Protirelin) in depressed alcoholic men. Arch. Gen. Psychiat., 36, 540– 547. LUCKE, C. & GILKE, S. (1971). Experimental modification of the sleep-induced peak of growth hormone secretion. J. clin. Endocrinol. Metab, 32, 729– 736. McCANN, S.M., FAWCETT, C.P. & KRULICH, L. (1974). Endocrine Physiology ed. S.M. McCann, pp. 31– 65. London: Butterworth. McLEOD, R.M. & LEHEMEYER, J.E. (1974). Studies on the mechanism of dopamine mediated inhibition of prolactin secretion. Endocrinology, 94, 1077– 1085. McNEILL, T.H. & SLADEK, J.R. (1978). Fluorescence—immunocytochemistry: simultaneous localization of catecholamines and gonadotrophin-releasing hormone. Science, 200, 72– 74. MALARKEY, W.B., CYRUS, J. & PAULSON, G.W. (1974). Dissociation of growth hormone and prolactin secretion in Parkinson's disease following chronic L-dopa therapy. J. clin. Endocrinol. Metab. 39, 229– 235. MARCANO DE COTTE, D., MENEZES, C.E.L., BENNETT, G.W. & EDWARDSON, J.A. (1980). Dopamine stimulates the degradation of gonadotrophin releasing hormone by rat synaptosomes. Nature, 283, 487– 489. MARTIN, J.B. (1973). Neural regulation of growth hormone secretion. New Engl. J. Med., 288, 1384– 1393. MARTIN, J.B., LAL, S., TOLIS, G. & FRIESEN, H.G. (1974). Inhibition by apomorphine of prolactin secretion in patients with elevated serum prolactin. J. clin. Endocrinol. Metab., 39, 180– 182. MARTIN, J.B., REICHLIN, S. & BROWN, G.M. (1977). In Clinical Neuroendocrinology, Contemporary Neurology. Philadelphia: G.A. Davis Co. MARTINI, L. & BESSER, G.M. (1977). Clinical Neuroendocrinology. New York: Academic Press. MASALA, A., MAGNA, A., DEVELLA, L., DELITALA, G. & NOVASIO, P.P. (1980). Inhibition of prolactin secretion by nomifensine in man. Clin. Endocrinol., 12, 237– 241. MELTZER, H.Y. & FANG, V.S. (1976). The effect of neuroleptics on serum prolactin in schizophrenic patients. Arch. Gen. Psychiat., 33, 279– 284. MELTZER, J.Y., GOODE, D.J., SCHYRE, P.M., YOUNG, M. & FANG, V.S. (1979). Effects of clozapine on human serum prolactin levels. Am. J. Psychiat., 136, 1550– 1554. MELTZER, H.Y., PIYAKALMALA, S., SCHYRE, P. & FANG, V.S. (1977). Lack of effect of tricyclic antidepressants on serum prolactin levels. Psychopharmacology, 51, 185– 187. MENDELS, J. (1976). Lithium in the treatment of depression. Am. J. Psychiat., 133, 373– 378. MENDELS, J., FRAZER, A. & CARROL, B. (1974). Growth hormone responses in depression. Am. J. Psychiat., 131, 1154– 1155. MENDELSON, J.H., ELLINGBOE, J., KEUHNLE, J.C. & MELLO, N.Y. (1978). Effects of naltrexone on mood and neuroendocrine function in normal adult males. Psychoneuroendocrinology, 3, 231– 236. MENDELSON, J.H., KUEHNLE, J., ELLINGBOE, J. & BABOR, T.F. (1974). Plasma testosterone levels, before, during and after chronic marihuana smoking. New Engl. J. Med., 292, 1051– 1055. MENDELSON, J.H., MELLO, N.K. & ELLINGBOE, J. (1977). Effects of acute alcohol intake on pituitary-gonadal hormones in normal human males. J. Pharmac. exp. Ther., 202, 676– 682. MENDELSON, J.H., MENDELSON, J.E. & PATCH, V.D. (1975). Plasma testosterone levels in heroin addiction and during methadone maintenance. J. Pharmac. exp. Ther., 192, 211– 217. MIRIN, S.M., MENDELSON, J.H., ELLINGBOE, J. & MYER, R.E. (1976). Acute effects of heroin and naltrexone on testosterone and gonadotrophin secretion in pilot study. Psychoneuroendocrinology, 1, 359– 369. MULLER, E.E., NISTICO, G. & SCAPAGINI, E. (1977). In Neurotransmitters and anterior pituitary function. New York: Academic Press. MULLER, E.E., GENAZZI, A.R. & MURU, S. (1978). Nomifensine: diagnostic test in hyperprolactinaemic states. J. clin. Endocrinol. Metab., 47, 1352– 1357. MURRAY, M.A.F., BANCROFT, J.H.J., ANDERSON, D.C., TENNENT, T.C. & CARR, P.J. (1975). Endocrine changes in male sexual deviants after treatment with anti-androgens, oestrogens or tranquillisers. J. Endocrinol., 67, 179– 188. NAKAI, Y., IMURA, H., YOSHUMI, T. & MATSUKURA, S. (1973). Adrenergic control mechanism for ACTH secretion in man. Acta Endocrinol., 74, 263– 270. NASRALLAH, H.A., FREED, W.J., ROGOL, A. & WYATT, R.J. (1977). Propranolol and prolactin. Lancet ii, 1175– 1176. NOEL, G.L., SUK, H.K., STONE, G.J. & FRANTZ, A.G. (1972). Human prolactin and growth hormone release during surgery and other conditions of stress. J. clin. Endocrinol. Metab, 35, 840– 851. PADFIELD, P.L., PARK, S.J., MORTON, J.J. & BRAIDWOOD, A.E. (1977). Plasma levels of antidiuretic hormone in patients receiving prolonged lithium therapy. Br. J. Psychiat., 130, 144– 147. PANDEY, G.N., GARVER, D.L., TAMMINGA, C., ERICKSON, S., SYAD, I.A. & DAVIS, J.M. (1977). Post-synaptic supersensitivity in schizophrenia. Am. J. Psychiat., 134, 518– 522. PARKES, J.D., DEBONO, A.G., JENNER, P. & WALTERS, J. (1977). Amphetamines, growth hormone and narcolepsy. Br. J. clin. Pharmac., 4, 343– 349. PARKES, J.D., DEBONO, A.G. & MARSDEN, C.D. (1976). Growth—hormone response in Parkinson's disease. Lancet, i, 483. PAYKEL, E.S. & ROWAN, P.R. (1979). Affective disorders. In Recent Advances in Clinical Psychiatry, ed. K. Granville-Grossman pp. 37– 90.London: Churchill-Livingstone. PERSKY, H., OBRIEN, C.P., FINE, E., HOWARD, W.J., KHAN, M.A. & BECK, R.W. (1977). The effect of alcohol and smoking on testosterone function and aggression in chronic alcoholics. Am. J. Psychiat., 134, 621– 625. PERSSON, T. & ROOS, B.E. (1967). 5-hydroxytryptophan for depression. Lancet, ii, 987– 988. PLANT, T.M., NAKAI, Y., BELCHETZ, P., KEOGH, E. & KNOBIL, E. (1978). The sites of action of estradiol and phentolamine in the inhibition of the pulsatile circhoral discharges of LH in the rhesus monkey. Endocrinology, 102, 1015– 1018. POST, R.M. (1975). Cocaine psychoses: A continuum model. Am. J. Psychiat., 132, 225– 231. PRANGE, A.J., WILSON, I.C., LARA, P.P., ALLTOP, L.B. & BREESE, G.R. (1972). Effects of thyrotropin-releasing hormone in depression. Lancet, ii, 999– 1002. RANDRUP, A. & MUNKVAD (1972). Evidence indicating an association between schizophrenia and dopaminergic hyperactivity in the brain. Orthomolec. Psychiat., 1, 2– 7. RAVITZ, A.J. & MOORE, K.E. (1977). Effects of amphetamine, methylphenidate and cocaine on serum prolactin concentrations in the male rat. Life Sci., 21, 267– 272. REES, L. (1970). M.D. thesis University of London. REES, L., BULLER, P.W.P., GOSLING, C. & BESSER, G.M. (1970). Adrenergic blockade and the corticosteroid and growth hormone response to methylamphetamine. Nature, 228, 565– 566. RIDGES, A.P., LAWTON, K., HARPER, P., GHOSH, C. & HINDSON, N. (1977). Propranolol in schizophrenia. Lancet, ii, 986. ROTROSEN, J., ANGRIST, O., GERSHON, S., PARQUIN, T., BRANCHEY, L., OLESHANSKY, M., HALPERN, F. & SACHAR, E.J. (1979). Neuroendocrine effects of apomorphine, Characterization of response patterns and application to schizophrenia research. Br. J. Psychiat., 135, 444– 456. RUBIN, R.T. (1977). Strategies of neuroendocrine research in psychiatry. In Neuroregulators and Psychic Disorders, Eds. E. Usdin, D.A. Hamburg & J.D. Barches, pp. 233– 241, New York: Oxford University Press. RUBIN, P., SWEZEY, S. & BLUSCHKE, T. (1979). Naloxone lowers plasma prolactin in man. Lancet, i, 1293. SACHAR, E.J., GRUEN, P.H., ALTMAN, N., HALPERN, F.S. & FRANTZ, A.G. (1976). Use of neuroendocrine techniques in psychopharmacological research. In Hormones, Behaviour and Psychopathology, E.J. Sachar, pp. 161– 176. New York: Raven Press. SALDANHA, V.F., HARVARD, C.W.H., BIRD, R. & GARDNER, A. (1972). The effect of chlorpromazine on pituitary function. Clin. Endocrinol., 1, 173– 180. SCANLON, M.F., GOMEZ-PAIN, A., MORA, B., COOK, D.B., DEWAR, J.H., HILDYARD, A. WEIGHTMAN, D.R., EVERED, D.C. & HALL, R. (1977). Effects of nomifensine, an inhibitor of endogenous catecholamine re-uptake in acromegaly, in hyperprolactinaemia and against stimulated prolactin release in man. Br. J. clin. Pharmac., 4, 191S– 197S. SCANLON, M.F., SMITH, REES B. & HALL, R. (1978). Thyroid-stimulating hormone: neuroregulation and clinical applications. Chem. Sci. Med., 55, 129– 138. SCHAEFER, C.F., GUNN, C.G. & DUBOWSKI, K.M. (1975). Normal plasma testosterone concentrations after marihuana smoking. New Eng. J. Med., 292, 867– 868. SCHILDKRAUT, J.J. (1965). The catecholamine hypothesis—a review of the supporting evidence. Am. J. Psychiat. 122, 509– 522. SCHWIMM, C., SCHWARK, H. McINTOSH, C., MILSTREY, H.R., WILLS, B. & KOBBERLING, J. (1976). Effect of dopamine receptor blocking agent pimozide on the growth hormone response to arginine and exercise and the spontaneous growth hormone fluctuations. J. clin. Endocrinol. Metab., 43, 1183– 1185. SHAAR, C.J., FREDERICKSON, R.C.A., DONINGER, M.B. & JACKSON, L. (1977). Enkephalin analogues and naloxone modulate the release of growth hormone and prolactin. Evidence for regulation by an endogenous opioid peptide in brain. Life Sci., 21, 853– 860. SHADER, R.I. & Di MASCIO R. (1970). Psychotropic drug side-effects Baltimore: Williams and Wilkins. SHAW, K.M., LEES, A.J., HAYES, S., ROSS, E.J., STERN, G.M. & THOMSON B.D. (1976). Growth hormone response to bromocriptine in Parkinsonism. Lancet, i, 194. SHERMAN, L., KIM, S., BENJAMIN, F. & KOLODNY, H. (1971). Effect of chlorpromazine on serum growth hormone concentration in man. New Engl. J. Med., 284, 72– 74. SINGER, I., ROTENBERG, D. & PUSCHETT, J.B. (1972). Lithium induced nephrogenic diabetes insipidus in vivo and in vitro studies. J. clin. Invest., 51, 108– 1091. SIRIS, S.S., VAN KAMMAN, D.P. & DE FRAITES, E.G. (1978). Serum prolactin and antipsychotic responses to pimozide in schizophrenia. Psychopharmac. Bull., 14, 8– 9. SLATER, S., DE LA VEGA, C.E., SHYLER, J. & MURPHY, D.L. (1978). Plasma prolactin secretion by fenfluramine and amphetamine. Psychopharmac. Bull., 12, 26. SMYTHE, G.A., COMPTON, P.J. & LAZARUS, L. (1976). Serotonergic control of human growth hormone secretion: the actions of L-dopa and 2-bromo-alpha-ergocryptine. In Growth Hormone and Related Peptides, eds. A. Pecile & E.E. Muller pp. 222– 225.Amsterdam: Excerpta Medica. SNYDER, S.H., ENNA, S.J. & YOUNG, A.B. (1977). Brain mechanisms associated with therapeutic actions of benzodiazepines: focus on neurotransmitters. Am. J. Psychiat. 134, 662– 664. STANLEY, M., LAUTIN, A., ROTROSEN, J. & GERSHON, S. (1979). Antipsychotic efficacy of metoclopramide. Do DA/neuroleptic receptors mediate the action of anti-psychotic drugs IRCS Medical Science, 7, 322. STRAIN, G.W. & STRAIN, J.J. (1978). Editorial: Psychosom. Med., 40, 2– 4. STRAUCH, G., VALCHE, J.C., MAHOUDEAU, J.A. & BRICAIR, H. (1977). Hormonal changes induced by bromocriptine (CB-154) at the early stage of treatment. J. clin. Endocrinol. Metab., 44, 588– 590. STUBBS, W.A., DELITALA, G., JONES, A., JEFFCOATE, W.J., EDWARDS, C.R.W., RATTER, S.J., BESSER, G.M., BLOOM, S.R. & ALBERTI, K.G.M.M. (1978). Hormonal and metabolic responses to an enkephalin analogue in normal man. Lancet, ii, 1225– 1227. SYLVALAHTI, E. & KANTO, J. (1975). Serum growth hormone, serum immunoreactive insulin and blood glucose responses to oral and intravenous diazepam in man. Int. J. clin. Pharmac., 12, 74. THORNER, M.O., BESSER, G.M., HAGAN, C. & McNEILLY, A.S. (1971). Introduction of a new stimulation test for prolactin: the sulpiride test: a comparison with other dynamic function tests. J. Endocrinol., 61, 83. THORNER, M.O., CHAIT, A., AITKEN, M., BENDER, G., BLOOM, S.M., MORTIMER, C.H., SANDERS, P., STUART-MASON, A. & BESSER, G.M. (1975). Bromocriptine treatment of acromegaly. Br. med. J., i, 299– 303. THORNER, M.O., RYAN, S.M., WASS, J.A.H., JONES, A., BOULOUX, P., WILLIAMS, S. & BESSER, G.M. (1978). Effect of dopamine agonist, lergotrile mesylate, on circulating anterior pituitary hormones in man. J. clin. Endocrinol. Metab., 47, 372– 378. TOLLIS, G., HICKEY, J. & GUYDA, H. (1975). Effect of morphine on serum growth hormone, cortisol, prolactin and thyroid stimulating hormone in man. J. clin. Endocrinol. Metab., 41, 797– 800. TURKINGTON, R.W. (1972). The clinical endocrinology of prolactin. Ad. int. Med., 18, 363. VAN THIEL, D.H., LESTER, R. & VAITUKAITIS, J. (1978). Evidence of a defect in pituitary secretion of luteinizing hormone in chronic alcoholic men. J. clin. Endocrinol. Metab., 47, 499– 507. WEICH, R.F. (1978). Acute effects of adrenergic blocking drugs and neuroleptic agents on pulsatile discharges of luteinizing hormone in the ovariectomized rat. Neuroendocrinology, 26, 108– 117. WEINER, R.I. & GANONG, W.F. (1978). Role of monoamines and histamine in the regulation of anterior pituitary hormone secretion. Physiol. Rev., 58, 905– 976. WELLS, B., SILVERSTONE, T. & REES, L. (1978). The effect of oral dextroamphetamine on PRL secretion in man. Neuropharmacology, 17, 1060– 1061. WIDERLOV, E. (1978). Effect of tricyclic antidepressants on human plasma levels of TSH/GH and PRL. Acta Psychiat. Scand., 58, 449– 456. WILLOUGHBY, J.O., BRAZEAU, P. & MARTIN, J.B. (1977). Effects of (+)-butaclamol on episodic GH and PRL release. Endocrinology, 101, 1298– 1303. WILSON, R.G., HAMILTON, J.R., BOYD, W.D., FORREST, A.P.M., COLE, E.N., BOYNS, A.R. & GRIFFITHS, K. (1975). The effect of long-term phenothiazine therapy on plasma prolactin. Br. J. Psychiat., 127, 71– 74. WRIGHT, J.W., FRY, D.E., MERRY, J. & MARKS, (1976). Abnormal hypothalamic—pituitary—gonadal function in chronic alcoholics. Br. J. Addiction, 71, 211– 215. YEN, S.C. (1977). Neuroendocrine aspects of the regulation of cyclic gonadotrophin release in women. In Clinical Neuroendocrinology, eds L. Martin & G.M. Besser pp. 175– 196.New York: Academic Press. YORKSTON, N.J., GRUZELIER, J.H., ZAKI, S.A., HOLLANDER, D., PITCHER, D.R. & SERGEANT, H.G.S. (1977). Propranolol as an adjunct to the treatment of schizophrenia. Lancet, ii, 575– 578. Citing Literature Volume10, Issue1July 1980Pages 5-21 ReferencesRelatedInformation
Referência(s)